Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome Copying Errors02:46

Genome Copying Errors

4.3K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
4.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Base Excision Repair01:54

Base Excision Repair

22.7K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
22.7K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.1K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.1K
RNA Editing02:23

RNA Editing

9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
Mismatch Repair01:20

Mismatch Repair

4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of risky driving behaviors in professional bus drivers: A questionnaire investigation.

Traffic injury prevention·2026
Same author

Systematic Metabolic Engineering and Fermentation Optimization of <i>Yarrowia lipolytica</i> for High-Yield Production of Scutellarin.

Journal of agricultural and food chemistry·2026
Same author

Development of a Core-Shell-Encapsulated Biosensor for On-Site Detection of Trace Chlorpyrifos.

ACS sensors·2026
Same author

Programmable DNA Origami-Based Protease Device for Precise and Direct Proteins Degradation.

Journal of the American Chemical Society·2026
Same author

Metabolic Engineering of Commensal Bacteria for Producing 5-Hydroxyindoleacetic Acid as a Therapeutic Strategy for Colitis.

ACS synthetic biology·2026
Same author

Effects of different organic amendments on soil cadmium availability and phytostabilization by poplar.

Physiology and molecular biology of plants : an international journal of functional plant biology·2026

Related Experiment Video

Updated: Jul 30, 2025

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
10:41

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers

Published on: June 24, 2019

8.4K

Overcoming Multidrug Resistance by Base-Editing-Induced Codon Mutation.

He-Hua Zhang1, Jian Xiang1, Bin-Cheng Yin1,2

  • 1Lab of Biosystem and Microanalysis, State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing Technology, East China University of Science and Technology, Shanghai 200237, China.

ACS Pharmacology & Translational Science
|May 18, 2023
PubMed
Summary
This summary is machine-generated.

This study uses a cytosine base editor (CBE) to inactivate genes for ATP binding cassette (ABC) transporters, overcoming multidrug resistance (MDR) in cancer chemotherapy. This approach restores drug sensitivity in resistant cancer cells.

More Related Videos

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.9K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Related Experiment Videos

Last Updated: Jul 30, 2025

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
10:41

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers

Published on: June 24, 2019

8.4K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.9K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.5K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biotechnology

Background:

  • Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
  • ATP binding cassette (ABC) transporters mediate drug efflux, causing MDR.
  • Targeting ABC transporters is crucial for overcoming MDR.

Purpose of the Study:

  • To implement a cytosine base editor (CBE) system for gene knockout of ABC transporters.
  • To reverse MDR in cancer cells by inactivating ABC transporter genes.
  • To evaluate the universality and applicability of the CBE system in restoring chemosensitivity.

Main Methods:

  • Utilized a cytosine base editor (CBE) system for precise nucleotide editing.
  • Induced stop codons (iSTOP) in ABC transporter genes to achieve knockout.
  • Assessed the downregulation of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP).

Main Results:

  • Successfully inactivated genes encoding ABC efflux transporters in MDR cells.
  • Significantly increased intracellular drug retention and cytotoxicity in MDR cancer cells.
  • Demonstrated substantial downregulation of P-gp and BCRP expression.

Conclusions:

  • The CBE system effectively knocks out ABC transporter genes, reversing MDR in cancer cells.
  • The system shows broad applicability and universality in restoring chemosensitivity.
  • CRISPR-based gene editing offers a promising strategy to combat cancer MDR.